Stage I Lung Cancer
6
2
2
1
Key Insights
Highlights
Success Rate
25% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 75/100
50.0%
3 terminated out of 6 trials
25.0%
-61.5% vs benchmark
0%
0 trials in Phase 3/4
100%
1 of 1 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 1 completed trials
Clinical Trials (6)
Avecure Flexible Microwave Ablation Probe For Lung Nodules
Cryodevitalization for the Treatment of Early Stage Lung Cancer, CRYSTAL Trial
Assessing and Addressing Follow-up Care Needs That Will Facilitate Care Transitions for Cancer Survivors
Pembrolizumab After Radiation Therapy and Chemotherapy in Limited Stage Small Cell Lung Cancer
High Dose Vitamin A Compound in Treating Participants With Resectable Non-Small Cell Lung Cancer
Fludeoxyglucose F-18-PET in Planning Lung Cancer Radiation Therapy